Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematopoietic Stem Cell MobilizationStem Cell TransplantationHematologic NeoplasmsBone MarrowGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanGraft SurvivalCombined Modality TherapyAntigens, CD34CyclophosphamideBusulfanHematopoietic Stem CellsTransplantation ChimeraBlood Component RemovalBone Marrow CellsWhole-Body IrradiationTissue DonorsTreatment OutcomeMultiple MyelomaRecurrenceAntineoplastic Combined Chemotherapy ProtocolsStem CellsMyeloablative AgonistsCord Blood Stem Cell TransplantationHistocompatibilityRemission InductionHistocompatibility TestingLeukemiaLymphoma, Non-HodgkinTransplantation, IsogeneicAnemia, AplasticEtoposideHematopoiesisLiver TransplantationImmunosuppressive AgentsAntineoplastic Agents, AlkylatingRetrospective StudiesDisease-Free SurvivalThiotepaLeukemia, Myeloid, AcuteInfectionTime FactorsSurvival AnalysisBone Marrow PurgingSurvival RatePOEMS SyndromeCarmustineGraft vs Leukemia EffectLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytarabineSalvage TherapyVidarabineMyelodysplastic SyndromesHodgkin DiseaseBlood CellsLymphocyte DepletionBone Marrow DiseasesVincristinePrecursor Cell Lymphoblastic Leukemia-LymphomaCytomegalovirus InfectionsKidney TransplantationPlatelet CountAmyloidosisLymphomaImmunosuppressionIfosfamideHematologic DiseasesHLA AntigensCyclosporineBone and BonesFollow-Up StudiesBlood Cell CountFatal OutcomeTransplantation ImmunologyOpportunistic InfectionsImmunophenotypingAcute DiseaseT-LymphocytesNeoplasmsHistiocytosis, Non-Langerhans-CellLeukocyte CountProspective StudiesLymphocyte TransfusionLeukocyte TransfusionGraft vs Tumor EffectNuclear FamilyRecombinant ProteinsHepatic Veno-Occlusive DiseaseMesenchymal Stem Cell TransplantationPrognosisFeasibility StudiesDoxorubicin